Core Viewpoint - Liansheng Chemical, established in 2007 and listed in 2022, is a leading fine chemical manufacturer in China, focusing on pharmaceutical and agricultural intermediates, with a full industry chain advantage [1] Group 1: Business Performance - In Q3 2025, Liansheng Chemical reported revenue of 506 million, ranking 56th among 79 companies in the industry, while the industry leader, Sinochem International, achieved revenue of 35.716 billion [2] - The net profit for the same period was 13.7671 million, placing the company 53rd in the industry, with the top performer, Hangyang Co., reporting a net profit of 850 million [2] Group 2: Financial Ratios - As of Q3 2025, Liansheng Chemical's debt-to-asset ratio was 20.98%, an increase from 16.90% year-on-year, which is below the industry average of 34.74% [3] - The gross profit margin for Q3 2025 was 10.84%, slightly up from 10.29% year-on-year, but still below the industry average of 19.93% [3] Group 3: Executive Compensation - The chairman, Mu Jianyu, received a salary of 507,700, a decrease of 900 from the previous year, while the general manager, Yu Kuai, earned 919,200, down 3,600 from 2023 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 16.41% to 7,270, while the average number of circulating A-shares held per account increased by 19.63% to 12,900 [5]

Core Viewpoint - Liansheng Chemical has shown a stable performance in terms of financing and stock trading, with significant growth in revenue and net profit year-on-year, indicating a positive outlook for the company. Financing and Trading Summary - On October 13, Liansheng Chemical's stock rose by 0.69%, with a trading volume of 38.83 million yuan. The financing buy-in amount was 5.03 million yuan, while the financing repayment was 3.98 million yuan, resulting in a net financing buy-in of 1.06 million yuan. The total financing and securities balance reached 53.86 million yuan, accounting for 1.89% of the circulating market value, which is above the 90th percentile of the past year, indicating a high level of financing activity [1]. - The company had no short-selling activity on October 13, with both short-selling repayment and sales at 0 shares, leading to a short-selling balance of 0 yuan, also above the 90th percentile of the past year, indicating a lack of short-selling interest [1]. Business Performance Summary - As of June 30, Liansheng Chemical had 8,697 shareholders, an increase of 2.52% from the previous period. The average number of circulating shares per person was 10,779, which increased by 238.68% [2]. - For the first half of 2025, Liansheng Chemical reported a revenue of 343 million yuan, representing a year-on-year growth of 13.95%. The net profit attributable to the parent company was 18.02 million yuan, reflecting a year-on-year increase of 9.61% [2]. Dividend Summary - Since its A-share listing, Liansheng Chemical has distributed a total of 97.52 million yuan in dividends. Over the past three years, the cumulative dividend payout has been 75.38 million yuan [3].

Group 1 - The core viewpoint of the news is that Liansheng Chemical experienced a decline in stock price and significant changes in financing activities on September 18, with a net financing outflow of 449.16 thousand yuan [1] - On September 18, Liansheng Chemical's stock price fell by 3.21%, with a trading volume of 41.93 million yuan [1] - The total financing and securities balance for Liansheng Chemical as of September 18 is 47.11 million yuan, which accounts for 1.66% of its market capitalization, indicating a high level compared to the past year [1] Group 2 - As of June 30, Liansheng Chemical had 8,697 shareholders, an increase of 2.52% from the previous period, with an average of 10,779 circulating shares per person, up by 238.68% [2] - For the first half of 2025, Liansheng Chemical reported a revenue of 34.3 million yuan, representing a year-on-year growth of 13.95%, and a net profit attributable to shareholders of 18.02 million yuan, up by 9.61% [2] Group 3 - Since its A-share listing, Liansheng Chemical has distributed a total of 97.52 million yuan in dividends, with 75.38 million yuan distributed over the past three years [3]

Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Liansheng Chemical, indicating a significant level of financing activity and a stable growth in revenue and profit [1][2]. - On August 28, Liansheng Chemical's stock fell by 1.56%, with a trading volume of 57.99 million yuan. The financing buy-in amount was 7.56 million yuan, while the financing repayment was 4.68 million yuan, resulting in a net financing buy-in of 2.88 million yuan [1]. - As of August 28, the total balance of margin trading for Liansheng Chemical was 52.19 million yuan, accounting for 1.82% of its market capitalization, which is above the 90th percentile level over the past year [1]. Group 2 - As of June 30, the number of shareholders for Liansheng Chemical was 8,697, an increase of 2.52% from the previous period. The average circulating shares per person rose to 10,779 shares, an increase of 238.68% [2]. - For the first half of 2025, Liansheng Chemical reported a revenue of 343 million yuan, representing a year-on-year growth of 13.95%. The net profit attributable to the parent company was 18.02 million yuan, reflecting a year-on-year increase of 9.61% [2]. - Since its A-share listing, Liansheng Chemical has distributed a total of 97.52 million yuan in dividends, with 75.38 million yuan distributed over the past three years [3].